Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Verheij

Showing results (141-150 of 182) with videos related to

Pageof 19
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 10, 2012
Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the NetherlandsJohan L Dikken, Valery E Lemmens, Michel W J M Wouters, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 30, 2010
Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumorsMenno van Lummel, Wim J van Blitterswijk, Stefan R Vink, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|July 17, 2021
Reply to Patel et al. 'Mucinous differentiation of rectal cancers: does it really impact oncological outcomes?'Tijmen Koëter, Rutger C H Stijns, Sebastiaan van Koeverden, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 29, 2021
Poor response at restaging MRI and high incomplete resection rates of locally advanced mucinous rectal cancer after chemoradiation therapyTijmen Koëter, Rutger C H Stijns, Sebastiaan van Koeverden, et al.
Cancer Research|September 14, 2019
Drug Sensitivity Prediction Models Reveal a Link between DNA Repair Defects and Poor Prognosis in HNSCCPaul B M Essers, Martijn van der Heijden, Caroline V M Verhagen, et al.
BMC Cancer|August 4, 2011
Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)Johan L Dikken, Johanna W van Sandick, H A Maurits Swellengrebel, et al.
Journal of Gastroenterology|July 31, 2023
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancerBenthe H Doeve, Jeanne A C Bakx, Peter D Siersema, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 16, 2020
Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapyMartijn van der Heijden, Paul B M Essers, Caroline V M Verhagen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2025
A novel approach to assess the prognostic value of toxicity profiles in gastric cancer patients undergoing preoperative treatmentRomy M van Amelsfoort, Patrick González, Rita Simões, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2022
Quality of Life Is Associated With Survival in Patients With Gastric Cancer: Results From the Randomized CRITICS TrialRomy M van Amelsfoort, Iris Walraven, Jacobien Kieffer, et al.
Pageof 19

Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
European Journal of Cancer (Oxford, England : 1990)|February 10, 2012
Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the NetherlandsJohan L Dikken, Valery E Lemmens, Michel W J M Wouters, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 30, 2010
Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumorsMenno van Lummel, Wim J van Blitterswijk, Stefan R Vink, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|July 17, 2021
Reply to Patel et al. 'Mucinous differentiation of rectal cancers: does it really impact oncological outcomes?'Tijmen Koëter, Rutger C H Stijns, Sebastiaan van Koeverden, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 29, 2021
Poor response at restaging MRI and high incomplete resection rates of locally advanced mucinous rectal cancer after chemoradiation therapyTijmen Koëter, Rutger C H Stijns, Sebastiaan van Koeverden, et al.
Cancer Research|September 14, 2019
Drug Sensitivity Prediction Models Reveal a Link between DNA Repair Defects and Poor Prognosis in HNSCCPaul B M Essers, Martijn van der Heijden, Caroline V M Verhagen, et al.
BMC Cancer|August 4, 2011
Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)Johan L Dikken, Johanna W van Sandick, H A Maurits Swellengrebel, et al.
Journal of Gastroenterology|July 31, 2023
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancerBenthe H Doeve, Jeanne A C Bakx, Peter D Siersema, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 16, 2020
Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapyMartijn van der Heijden, Paul B M Essers, Caroline V M Verhagen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2025
A novel approach to assess the prognostic value of toxicity profiles in gastric cancer patients undergoing preoperative treatmentRomy M van Amelsfoort, Patrick González, Rita Simões, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2022
Quality of Life Is Associated With Survival in Patients With Gastric Cancer: Results From the Randomized CRITICS TrialRomy M van Amelsfoort, Iris Walraven, Jacobien Kieffer, et al.
Pageof 19